Skip to main content

Advertisement

Log in

Bariatric Surgery Can Correct Iron Depletion in Morbidly Obese Women: A Link with Chronic Inflammation

  • Research Article
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Background

Obesity is associated with a chronic and low-grade inflammation which may cause hypoferremia as seen in patients with chronic inflammatory diseases. The aim of the present study was to investigate the relationship between iron status and markers of inflammation in morbidly obese women and the effect of bariatric surgery.

Methods

Our cohort of patients consisted of 178 morbidly obese females selected for bariatric surgery. Clinical and biochemical data were recorded before surgery, and histopathological studies were carried out on preoperative liver biopsy samples. Fifty-five patients have been followed up after bariatric surgery.

Results

A high prevalence of iron depletion was present in this cohort, with 53% having a transferrin saturation ratio below 0.20. Iron depletion was significantly correlated with raised levels of indices of inflammation, C-reactive protein (CRP), orosomucoid and haptoglobin), and with the white blood cell count. In multivariate analysis, orosomucoid and CRP were independently associated with iron depletion. Moreover, 6 months after bariatric surgery, inflammation level decreased, which was inversely correlated with the increase in transferrin saturation.

Conclusions

Iron depletion is common in morbidly obese women. Low-grade chronic inflammation associated with obesity could be a modulator of iron uptake and utilization. Bariatric surgery may reduce chronic inflammation and improve iron status.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kopelman PG. Obesity as a medical problem. Nature. 2000;404:635–43.

    PubMed  CAS  Google Scholar 

  2. Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA. 2006;295:1549–55.

    Article  PubMed  CAS  Google Scholar 

  3. Visser M, Bouter LM, McQuillan GM, et al. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999;282:2131–5.

    Article  PubMed  CAS  Google Scholar 

  4. Hanusch-Enserer U, Cauza E, Spak M, et al. Acute-phase response and immunological markers in morbid obese patients and patients following adjustable gastric banding. Int J Obes Relat Metab Disord. 2003;27:355–61.

    Article  PubMed  CAS  Google Scholar 

  5. Anty R, Bekri S, Luciani N, et al. The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, type 2 diabetes, and NASH. Am J Gastroenterol. 2006;101:1824–33.

    Article  PubMed  CAS  Google Scholar 

  6. Ford ES. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care. 1999;22:1971–7.

    Article  PubMed  CAS  Google Scholar 

  7. Chiellini C, Santini F, Marsili A, et al. Serum haptoglobin: a novel marker of adiposity in humans. J Clin Endocrinol Metab. 2004;89:2678–83.

    Article  PubMed  CAS  Google Scholar 

  8. Nieman DC, Nehlsen-Cannarella SI, Henson DA, et al. Immune response to obesity and moderate weight loss. Int J Obes Relat Metab Disord. 1996;20:353–60.

    PubMed  CAS  Google Scholar 

  9. Ahmad KA, Ahmann JR, Migas MC, et al. Decreased liver hepcidin expression in the Hfe knockout mouse. Blood Cells Mol Dis. 2002;29:361–66.

    Article  PubMed  CAS  Google Scholar 

  10. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome—a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23:469–80.

    Article  PubMed  CAS  Google Scholar 

  11. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860–7.

    Article  PubMed  CAS  Google Scholar 

  12. Shuldiner AR, Yang R, Gong DW. Resistin, obesity and insulin resistance—the emerging role of the adipocyte as an endocrine organ. N Engl J Med. 2001;345:1345–6.

    Article  PubMed  CAS  Google Scholar 

  13. Weisberg SP, McCann D, Desai M, Rosenbaum M, et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112:1796–808.

    PubMed  CAS  Google Scholar 

  14. Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112:1821–30.

    PubMed  CAS  Google Scholar 

  15. Wu H, Ghosh S, Perrard XD, et al. T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation. 2007;115:1029–38.

    Article  PubMed  CAS  Google Scholar 

  16. Kral JG, Thung SN, Biron S, et al. Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis. Surgery. 2004;135:48–58.

    Article  PubMed  Google Scholar 

  17. Dixon JB, Bhathal PS, Hughes NR, et al. Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology. 2004;39:1647–54.

    Article  PubMed  Google Scholar 

  18. Wenzel BJ, Stults HB, Mayer J. Hypoferraemia in obese adolescents. Lancet. 1962;2:327–8.

    Article  PubMed  CAS  Google Scholar 

  19. Seltzer CC, Wenzel BJ, Mayer J. Serum iron and iron-binding capacity in adolescents. I. Standard values. Am J Clin Nutr. 1963;13:343–53.

    PubMed  CAS  Google Scholar 

  20. Pinhas-Hamiel O, Newfield RS, Koren I, et al. Greater prevalence of iron deficiency in overweight and obese children and adolescents. Int J Obes Relat Metab Disord. 2003;27:416–8.

    Article  PubMed  CAS  Google Scholar 

  21. Nead KG, Halterman JS, Kaczorowski JM, et al. Overweight children and adolescents: a risk group for iron deficiency. Pediatrics. 2004;114:104–8.

    Article  PubMed  Google Scholar 

  22. Wallace DF, Pedersen P, Dixon JL, et al. Novel mutation in ferroportin1 is associated with autosomal dominant hemochromatosis. Blood. 2002;100:692–4.

    Article  PubMed  CAS  Google Scholar 

  23. Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467–74.

    Article  PubMed  CAS  Google Scholar 

  24. Scheuer P, Lefkowitch J. Liver biopsy interpretation. London: Saunders; 1994.

    Google Scholar 

  25. Yanoff LB, Menzie CM, Denkinger B, et al. Inflammation and iron deficiency in the hypoferremia of obesity. Int J Obes. 2007;31(9):1412–9.

    Google Scholar 

  26. Nemeth E, Valore EV, Territo M, et al. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2003;101:2461–3.

    Article  PubMed  CAS  Google Scholar 

  27. Bekri S, Gual P, Anty R, et al. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology. 2006;131:788–96

    Article  PubMed  CAS  Google Scholar 

  28. Laine F, Jouannolle AM, Morcet J, et al. Phenotypic expression in detected C282Y homozygous women depends on body mass index. J Hepatol. 2005;43:1055–9.

    Article  PubMed  CAS  Google Scholar 

  29. Kis AM, Carnes M. Detecting iron deficiency in anemic patients with concomitant medical problems. J Gen Intern Med. 1998;13:455–61.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The help of Dr. E Marine-Barjoan for the statistical analysis of the data is greatly acknowledged.

This work was supported by grants from the Institut National de la Santé et de la Recherche Médicale (France) (ANR-05-PCOD-025-02 and PNRHGE to PG), the University of Nice, the Programme Hospitalier de Recherche Clinique, the Comité Doyen Jean Lépine (Nice, France) and the French Research Ministery (ACI JC5327, to PG). This work is part of the project “Hepatic and adipose tissue and functions in the metabolic syndrome” (HEPADIP, see http://www.hepadip.org/), which is supported by the European Commission as an Integrated Project under the 6th Framework Programme (Contract LSHM-CT-2005-018734). RA was successively supported by the Fondation pour la Recherche Médicale (France), the APPERT institute (Paris, France) and Nestlé Nutrition (Paris, France). YLMB and PG were recipient of Interface Hospital Grant from CHU de Nice.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Soumeya Bekri.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Anty, R., Dahman, M., Iannelli, A. et al. Bariatric Surgery Can Correct Iron Depletion in Morbidly Obese Women: A Link with Chronic Inflammation. OBES SURG 18, 709–714 (2008). https://doi.org/10.1007/s11695-007-9276-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-007-9276-y

Keywords

Navigation